About the project:

Share:

Research areas in the project

Study of the antitumor effects of photodynamic therapy (PDT) and compounds inducing endoplasmic reticulum stress.

Project leader: prof. Jakub Gołąb, MD, PhD (Medical University of Warsaw).
Project partners: KU Leuven (Belgium), University College Dublin (Ireland).

Application of anti-CD20 monoclonal antibodies in cancer treatment.

Project leader: Magdalena Winiarska, PhD (Medical University of Warsaw).
Project partner: Universite de la Mediterranée (Marseille, France).

Study and identification of potential target moleculesand efficiency markers in the treatment of chronic myeloid leukaemia.

Project leader: Tomasz Stokłosa, MD, PhD (Medical University of Warsaw).
Project partner: University Hospital of Ulm (Germany).

Vascular mechanisms in metastasis.

Project leader: prof. Zbigniew Gaciong, MD, PhD (Medical University of Warsaw).
Project partner: Karolinska Institutet (Stockholm, Sweden).

Study of metalloprotease inhibitors in prostate cancer.

Project leader: Paweł Włodarski, MD, PhD (Medical University of Warsaw).
Project partners: Radboud University Medical Center Nijmegen (Netherlands), Saarland University (Germany).

Study of the role of microRNA sequence variance in theefficiency of cancer treatment.

Project leader: Krystian Jażdżewski, MD, PhD (Medical University of Warsaw).
Project partners: University of Ferrara (Italy), Leeds Institute for Molecular Medicine, University of Leeds (UK).

Study of circulating tumour cells in the colorectal cancer diagnostics.

Project leader: Piotr Religa, MD, PhD (Medical University of Warsaw).
Project partner: Karolinska Institutet (Stockholm, Sweden).

Molecular and genomic study of carcinogenesis related to infections with human papilloma virus.

Project leader: prof. Sławomir Majewski, MD, PhD (Medical University of Warsaw).
Project partner: University of Cologne (Germany).

Study of proteasome inhibitors and mechanisms of protein folding as potential targets in personalised cancer therapy.

Project leader: Dominika Nowis, MD, PhD (Medical University of Warsaw).
Project partner: University of Verona (Italy).

Role of peroxiredoxin 1 in human malignancies

Project leader: Radosław Zagożdżon, MD, PhD (Medical University of Warsaw).
Project partners: University College Dublin; Beaumont Hospital.